Satellos Bioscience
$0.35
0
+$0+0% Friday 18:49
Statistics
Day High
0.36
Day Low
0.36
52W High
0.58
52W Low
0.22
Volume
1,500
Avg. Volume
15,854
Mkt Cap
40.6M
P/E Ratio
0
Dividend Yield
-
Dividend
-
Earnings
23NovConfirmed
Expected EPS
-0.07
Actual EPS
-0.05
People Also Follow
This list is based on the watchlists of people on Stock Events who follow MSCLF. It's not an investment recommendation.
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
About
Satellos Bioscience Inc., a regenerative medicine company, develops therapeutics to treat degenerative muscle diseases. Its lead program focuses on the development of oral therapeutic drug to correct muscle stem cell polarity and restore the body's innate muscle repair and regeneration process. The company was incorporated in 2012 and is headquartered in Toronto, Canada.
Show more...
CEO
Employees
3
Country
CA
ISIN
CA80401L3083
WKN
000A3CSSM